4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000089
Options or other derivatives
- Chief Financial Officer returned 1,250,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Davis Blaine · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-13 | Returned to the company : show line 1 in the form Employee Stock Option (right to buy) | −1,250,000 | $0.79 | $987,500 | 0 | D |
Loading xslF345X05/wk-form4_1700087199.xml…